Home / Benefits of plant science / Biotechnology Benefits & Safety Database / Global Status of Commercialized Biotech/GM Crops: 2007 (ISAAA Briefing No 37) Executive Summary

Global Status of Commercialized Biotech/GM Crops: 2007 (ISAAA Briefing No 37) Executive Summary (2007)

This paper is relevant to the Agronomic, Socio-Economic, Environmental, and Developing Country categories in the following areas:

Crops:	Wheat, Maize, Cotton, Potato, Soybean, Rice, Oilseed Rape, Sweet Potato, Papaya, and Other
Traits:	Insect Resistance, Herbicide Tolerance, and Insect Res. (BT)
Countries:	Global
Regions:	Middle East, South America, North America, Europe, Australia / NZ, Asia, and Africa
ImpactAreas:	Agronomic, Environmental, Socio-Economic, and Developing Countries

Abstract or Summary:

In 2007, for the twelfth consecutive year, the global area of biotech crops continued to soar. Remarkably, growth continued at a sustained double-digit growth rate of 12%, or 12.3 million hectares (30 million acres) – the second highest increase in global biotech crop area in the last five years – reaching 114.3 million hectares (282.4 million acres). The number of countries planting biotech crops increased to 23, and comprised 12 developing countries and 11 industrial countries with the first eight of these countries grew more than 1 million hectares each.

Download Global Status of Commercialized Biotech/GM Crops: 2007 (ISAAA Briefing No 37) Executive Summary (held on an external server, and so may require additional authentication details)

* CropLife International gives full acknowledgement to the author and publisher of this article (see download for details).